The Landmark Series: Axillary Management in Breast Cancer

Carla S. Fisher; Julie A. Margenthaler; Kelly K. Hunt; Theresa Schwartz

doi:10.1245/s10434-019-08154-5

The Landmark Series: Axillary Management in Breast Cancer

Carla S. Fisher, Julie A. Margenthaler, Kelly K. Hunt, Theresa Schwartz

Breast Surgical Oncology

Research output: Contribution to journal › Article › peer-review

37 Scopus citations

Abstract

The evolution in axillary management for patients with breast cancer has resulted in multiple dramatic changes over the past several decades. The end result has been an overall deescalation of surgery in the axilla. Landmark trials that have formed the basis for the current treatment guidelines are reviewed herein.

Original language	English (US)
Pages (from-to)	724-729
Number of pages	6
Journal	Annals of surgical oncology
Volume	27
Issue number	3
DOIs	https://doi.org/10.1245/s10434-019-08154-5
State	Published - Mar 1 2020

ASJC Scopus subject areas

Surgery
Oncology

Access to Document

10.1245/s10434-019-08154-5

Cite this

@article{c2534c9f47b54ffcbe39f649bf81c2e4,

title = "The Landmark Series: Axillary Management in Breast Cancer",

abstract = "The evolution in axillary management for patients with breast cancer has resulted in multiple dramatic changes over the past several decades. The end result has been an overall deescalation of surgery in the axilla. Landmark trials that have formed the basis for the current treatment guidelines are reviewed herein.",

author = "Fisher, {Carla S.} and Margenthaler, {Julie A.} and Hunt, {Kelly K.} and Theresa Schwartz",

year = "2020",

month = mar,

day = "1",

doi = "10.1245/s10434-019-08154-5",

language = "English (US)",

volume = "27",

pages = "724--729",

journal = "Annals of surgical oncology",

issn = "1068-9265",

publisher = "Springer New York",

number = "3",

}

TY - JOUR

T1 - The Landmark Series

T2 - Axillary Management in Breast Cancer

AU - Fisher, Carla S.

AU - Margenthaler, Julie A.

AU - Hunt, Kelly K.

AU - Schwartz, Theresa

PY - 2020/3/1

Y1 - 2020/3/1

N2 - The evolution in axillary management for patients with breast cancer has resulted in multiple dramatic changes over the past several decades. The end result has been an overall deescalation of surgery in the axilla. Landmark trials that have formed the basis for the current treatment guidelines are reviewed herein.

AB - The evolution in axillary management for patients with breast cancer has resulted in multiple dramatic changes over the past several decades. The end result has been an overall deescalation of surgery in the axilla. Landmark trials that have formed the basis for the current treatment guidelines are reviewed herein.

UR - http://www.scopus.com/inward/record.url?scp=85077066411&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85077066411&partnerID=8YFLogxK

U2 - 10.1245/s10434-019-08154-5

DO - 10.1245/s10434-019-08154-5

M3 - Article

C2 - 31863417

AN - SCOPUS:85077066411

SN - 1068-9265

VL - 27

SP - 724

EP - 729

JO - Annals of surgical oncology

JF - Annals of surgical oncology

IS - 3

ER -

The Landmark Series: Axillary Management in Breast Cancer

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this